NEU 3.23% $13.11 neuren pharmaceuticals limited

NEU is materially undervalued, page-47

  1. 411 Posts.
    lightbulb Created with Sketch. 1280
    Reata's Skyclarys got FDA approval in Feb 2023 and then received EU approval in Feb 2024, 12 months later.
    Last edited by KJK1959: 12/08/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.11
Change
0.410(3.23%)
Mkt cap ! $1.675B
Open High Low Value Volume
$13.02 $13.12 $12.89 $8.524M 654.7K

Buyers (Bids)

No. Vol. Price($)
3 5580 $13.04
 

Sellers (Offers)

Price($) Vol. No.
$13.11 11667 1
View Market Depth
Last trade - 16.10pm 17/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.